Market cap
$1,500 Mln
Revenue (TTM)
$82 Mln
P/E Ratio
--
P/B Ratio
8.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-227 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0.9
-
Book Value
$3.2
-
EPS
$-4.1
-
Face value
--
-
Shares outstanding
56,228,300
10 Years Aggregate
CFO
$-967.31 Mln
EBITDA
$-1,229.02 Mln
Net Profit
$-1,270.25 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zogenix Inc (ZGNX)
| 64.2 | 2.3 | 114.8 | 28.6 | -19.4 | 22.6 | 2.1 |
|
BSE Sensex*
| -8.9 | -1.2 | 3.2 | -3.3 | 6.0 | 6.0 | 10.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Zogenix Inc (ZGNX)
| -18.7 | -61.7 | 43.0 | -8.9 | 229.6 | -17.6 | 34.5 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zogenix Inc (ZGNX)
|
26.7 | 1,500.2 | 81.7 | -227.4 | -259.6 | -82.9 | -- | 8.3 |
| 13.8 | 850.9 | 0.0 | -175.9 | -- | -106.8 | -- | 5.7 | |
| 12.1 | 2,151.8 | 549.1 | 17.9 | -6.3 | 1.4 | 123.8 | 1.7 | |
| 4.7 | 1,111.4 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 12.9 | 587.5 | 0.0 | -29.0 | 0.0 | -20.4 | -- | 2.0 | |
| 16.8 | 2,261.9 | 120.3 | -57.5 | -108.2 | -9.9 | -- | 4.1 | |
| 11.5 | 828.1 | 366.5 | 9.3 | 8.3 | 3.4 | 83.6 | 3.1 | |
| 3.6 | 654.8 | 4.1 | -187.9 | -4,613.1 | -233.9 | -- | 0.3 | |
| 13.5 | 834.1 | 0.6 | -60.0 | -9,892.6 | -119 | -- | 21.8 | |
| 25.5 | 2,927.9 | 449.6 | -188.2 | -41.1 | -28.5 | -- | 5.0 |
Shareholding Pattern
View DetailsAbout Zogenix Inc (ZGNX)
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose... fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California. Read more
-
Co-Founder, CEO, Pres & Director
Dr. Stephen J. Farr
-
Co-Founder, CEO, Pres & Director
Dr. Stephen J. Farr
-
Headquarters
EmeryVille, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zogenix Inc (ZGNX)
What is the current share price of Zogenix Inc (ZGNX) Today?
The share price of Zogenix Inc (ZGNX) is $26.68 (NASDAQ) as of 07-Mar-2022 09:30 EDT. Zogenix Inc (ZGNX) has given a return of -19.39% in the last 3 years.
What is the current PB & PE ratio of Zogenix Inc (ZGNX)?
Since, TTM earnings of Zogenix Inc (ZGNX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-4.00 |
5.08 |
2020 |
-5.16 |
2.92 |
2019 |
-5.34 |
9.15 |
2018 |
-11.18 |
2.65 |
2017 |
-8.53 |
3.59 |
What is the 52 Week High and Low of Zogenix Inc (ZGNX)?
The 52-week high and low of Zogenix Inc (ZGNX) are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Zogenix Inc (ZGNX)?
Zogenix Inc (ZGNX) has a market capitalisation of $ 1,500 Mln as on 08-Mar-2022. As per SEBI classification, it is a company.
Should I invest in Zogenix Inc (ZGNX)?
Before investing in Zogenix Inc (ZGNX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.